(HealthDay)—Capsaicin nasal spray is effective for mixed rhinitis (MR) patients, who have more than one major etiologic factor involved in the mucosal pathology, according to a study published online July 16 in Allergy.
Jul 20, 2017
0
32
(HealthDay)—For patients with grass pollen-induced allergic rhinitis (AR), booster allergen immunotherapy (AIT) using tyrosine-absorbed grass pollen allergoids containing the adjuvant monophosphoryl lipid A (MPL) prevents ...
Jul 14, 2017
0
3
(HealthDay)—Vitamin D supplementation seems not to prevent allergies in pregnant women, breastfeeding women, or infants, though there is very little evidence about the association between vitamin D and allergic diseases, ...
Jul 13, 2017
0
9
(HealthDay)—There is a causal relationship between increasing body mass index (BMI) and asthma and decreased lung function, according to a study published online July 4 in Allergy.
Jul 10, 2017
0
16
(HealthDay)—There is a correlation between bacterial colonization and food sensitization and allergy in young children, according to a study published online June 20 in Allergy.
Jun 27, 2017
0
52
(HealthDay)—For patients with a significant response to allergen challenge, omalizumab induces protective effects against early (EAR) and late allergic reactions (LAR), according to a study published online June 5 in Allergy.
Jun 9, 2017
0
13
(HealthDay)—Administration of allergen immunotherapy (AIT) in patients with allergic asthma leads to lower short-term symptom and medication scores, according to a review published online May 19 in Allergy.
Jun 4, 2017
0
62
(HealthDay)—Certain plasma microRNAs (miRNAs) are differentially regulated in allergic asthma and correlate with clinical characteristics, according to an experimental study published online May 17 in Allergy.
Jun 1, 2017
0
8
(HealthDay)—Chronic spontaneous urticaria (CSU) interferes with sleep and daily activity, impairing work productivity, and patients frequently report angioedema, according to a study published online May 19 in Allergy.
May 31, 2017
0
38
(HealthDay)—For patients with food allergy, quality of life (QOL) following oral immunotherapy (OIT) improves for some but deteriorates in others, according to a study published online May 22 in Allergy.
May 30, 2017
0
12
